Clinical effects of resveratrol (review of the literature)


Cite item

Full Text

Abstract

The review presents the data of world literature on the clinical effects of natural phytoalexin - resveratrol. The mechanisms underlying the antioxidant, cardioprotective, neuroprotective, phytoestrogens, anti-aging, anti-inflammatory, hepatoprotective and metabolic effects of resveratrol are discussed in detail.

About the authors

Yu B Uspenskaya

ГБОУ ВПО Первый Московский государственный медицинский университет им. И.М.Сеченова Минздрава России

канд. мед. наук, вед. науч. сотр. НИО Женского здоровья НИЦ

References

  1. Asensi M, Medina I, Ortega A et al. Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic Biol Med 2002; 33: 387-98.
  2. Atmaca N, Atmaca H.T, Kanici A, Anteplioglu T. Protective effect of resveratrol on sodium fluoride - induced oxidative stress, hepatotoxicity and neurotoxicity in rats. Food Chem Toxicol 2014; p. 245-78.
  3. Aubin M.C, Lajoie C, Clement R et al. Female rats fed a high - fat diet were associated with vascular dysfunction and cardiac fibrosis in the absence of overt obesity and hyperlipidemia: therapeutic potential of resveratrol. J Pharmacol Exp Ther 2008; 325: 961-8.
  4. Banerjee S, Bueso-Ramos C, Aggarwal B.B. Suppression of 7,12-dimethyl - benz(a) anthracene - induced mammary carcinogenesis in rats by resveratrol: Role of nuclear factor - kappa B, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res 2002; 62: 4945-54.
  5. Baur J.A, Pearson K.J, Price N.L et al. Resveratrol improves health and survival of mice on a high - calorie diet. Nature 2006; 444 (7117): 337-42.
  6. Baur J.A, Sinclair D A. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006; 5: 493-506.
  7. Behbahani J, Thandapilly S.J, Louis X.L, Huang Y et al. Resveratrol and small artery compliance and remodeling in the spontaneously hypertensive rat. Am J Hypertens 2010; 23 (12): 1273-8.
  8. Bhat K.P, Kosmeder J.W, Pezzuto J.M. Biological effects of resveratrol. Antioxid Redox Signal 2001; 3 (6): 1041-64.
  9. Bhat K.P.L, Lantvit D, Christov K et al. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res 2001; 61 (20): 7456-63.
  10. Bishayee A, Barnes K.F, Bhatia D et al. Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine - initiated rat hepatocarcinogenesis. Cancer Prev Res 2010; 3: 753-63.
  11. Bowers J.L, Tyulmenkov V.V, Jernigan S.C, Klinge C.M. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology 2000; 141 (10): 3657-67.
  12. Brown V.A, Patel K.R, Viskaduraki M et al. Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics and Effect on the Insulin - like Growth Factor Axis. Cancer Res 2010; 70: 9003-11.
  13. Chan V, Fenning A, Iyer A, Hoey A, Brown L. Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats. Curr Pharm Biotechnol 2011; 12: 429-36.
  14. Chen C.L, Yang H.I, Yang W.S et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow - up study in Taiwan. Gastroenterology 2008; 135: 111-21.
  15. Chen M.L, Li J, Xiao W.R et al. Protective effect of resveratrol against oxidative damage of UVA irradiated HaCaT cells. Jhong Nan Da Xue Xue Bao Yi Ban 2006; 31: 635-9.
  16. Chen Y.R, Yi F.F, Li X.Y et al. Resveratrol attenuates ventricular arrhythmias and improves the long - term survival in rats with myocardial infarction. Cardiovasc Drugs Ther 2008; 22: 479-85.
  17. Csiszar A, Labinskyy N, Olson S et al. Resveratrol prevents monocrotaline - induced pulmonary hypertension in rats. Hypertension 2009; 54: 668-75.
  18. Das S, Mitrovsky G, Vasanthi H.R et al. Antiaging Properties of a Grape - Derived Antioxidant Are Regulated by Mitochondrial Balance of Fusion and Fission Leading to Mitophagy Triggered by a Signaling Network of Sirt1- Sirt3-Foxo3-PINK1-PARKIN. Oxid Med Cell Longev 2014; 2014: 345105.
  19. Dolinsky V.W, Dyck J.R. Calorie restriction and resveratrol in cardiovascular health and disease. Biochim Biophys Acta 2011; 1812: 1477-89.
  20. Elliott P.J, Walpole S, Morelli L et al. Resveratrol/SRT501. Sirtuin SIRT1 activator, Treatment of type 2 diabetes. Drugs Fut 2009; 34: 291-5.
  21. Frémont L. Biological effects of resveratrol. Life Sci 2000; 66 (8): 663-73.
  22. Ghanim H, Sia C.L, Abuaysheh S et al. An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol. J Clin Endocrinol Metab 2010; 95 (9): 2-8.
  23. Ghanim H, Sia C.L, Korzeniewski K et al. A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high - fat, high - carbohydrate meal. J Clin Endocrinol Metab 2011; 96 (5): 1409-14.
  24. Harper C.E, Cook L.M, Patel B.B et al. Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats. Prostate 2009; 69: 1668-82.
  25. Howitz K.T, Bitterman K.J, Cohen H.Y et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003; 425 (6954): 191-6.
  26. Jimenez-Gomez Y, Mattison J.A, Pearson K.J et al. Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high - fat, high - sugar diet. Cell Metab 2013; 18 (4): 533-45.
  27. Kasdallah-Grissa A, Mornagui B, Aouani E et al. Resveratrol, a red wine polyphenol, attenuates ethanolinduced oxidative stress in rat liver. Life Sci 2007; 80: 1033-9.
  28. Khan M.M, Ahmad A, Ishrat T et al. Resveratrol attenuates 6-hydroxydopamine - induced oxidative damage and dopamine depletion in rat model of Parkinson’s disease. Brain Res 2010; 1328: 139-51.
  29. Kim J, Cha Y-N, Surh Y-J. A protective role of nuclear factor - erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutation Research 2010; 690 (1-2): 12-23.
  30. Kitada M, Koya D. Renal protective effects of resveratrol. Oxid Med Cell Longev 2013; p. 1155-60.
  31. Kumar A, Negi G, Sharma S.S. Neuroprotection by resveratrol in diabetic neuropathy: concepts & mechanisms. Curr Med Chem 2013; 20 (36): 4640-5.
  32. Lee T.H, Seo J.O, Baek S.H, Kim S.Y. Inhibi ory effects of resveratrol on melanin synthesis in ultraviolet B-induced pigmentation in Guinea pig skin. Biomol Ther (Seoul) 2014; 22 (1): 35-40.
  33. Li H, Fostermann U. Resveratrol: a multifunctional compound improving endothelial function. Cardiovasc Drugs Ther 2009; 23: 425-9.
  34. Li S.Y, Wang X.B, Kong L.Y. Design, synthesis and biological evaluation of imine resveratrol derivatives as multi - targeted agents against Alzheimer's disease. Eur J Med Chem 2014; 71: 36-45.
  35. Lin C.J, Chen T.H, Yang L.Y, Shih C.M. Resveratrol protects astrocytes against traumatic brain injury through inhibiting apoptotic and autophagic cell death. Cell Death Dis 2014; 5: 1147-50.
  36. Lin H.C, Chen Y.F, Hsu W.H et al. Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model. Cancer Prev Res (Phila) 2012; 5 (7): 952-62.
  37. Lin J.F, Lin S.M, Chih C.L et al. Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats. Life Sci 2008; 83: 313-7.
  38. Lu K.T, Ko M.C, Chen B.Y et al. Neuroprotective Effects of Resveratrol on MPTP-Induced Neuron Loss Mediated by Free Radical Scavenging. J Agric Food Chem 2008; 56: 6910-3.
  39. Macarulla M.T, Alberdi G, Gomez S et al. Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet. J Physiol Biochem 2009; 65: 369-76.
  40. Mbimba T, Awale P, Bhatia D et al. Alteration of hepatic proinflammatory cytokines is involved in the resveratrol - mediated chemoprevention of chemically - induced hepatocarcinogenesis. Curr Pharm Biotechnol 2012; 13: 229-34.
  41. Miatello R, Vazquez M, Renna N et al. Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose - fed rats. Am J Hypertens 2005; 18: 864-70.
  42. Mikstacka R, Rimando A.M, Ignatowicz E. Antioxidant effect of transresveratrol, pterostilbene, quercetin and their combinations in human erythrocytes in vitro. Plant Foods Hum Nutr 2010; 65 (1): 57-63.
  43. Mueller S.O, Simon S, Chae K et al. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci 2004; 80 (1): 14-25.
  44. Narayanan N.K, Nargi D, Randolph C, Narayanan B.A. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int J Cancer 2009; 125: 1-8.
  45. Oomen C.A, Farkas E, Roman V et al. Resveratrol preserves cerebrovascular density and cognitive function in aging mice. Front Aging Neurosci 2009; 1: 4-5.
  46. Patel K.R, Brown V.A, Jones D.J et al. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res 2010; 70: 7392-9.
  47. Ranney A, Petro M.S. Resveratrol protects spatial learning in middleaged C57BL/6 mice from effects of ethanol. Behav Pharmacol 2009; 20: 330-6.
  48. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008; 22: 659-61.
  49. Rege S.D, Kumar S, Wilson D.N et al. Resveratrol protects the brain of obese mice from oxidative damage. Oxid Med Cell Longev 2013; p. 419-20.
  50. Saleh M.C, Connell B.J, Saleh T.M. Resveratrol preconditioning induces cellular stress proteins and is mediated via NMDA and estrogen receptors. Neuroscience 2010; 166: 445-54.
  51. Scherz-Shouval R, Elazar Z. ROS, mitochondria and the regulation of autophagy. Trends in Cell Biology 2007; 17 (9): 422-7.
  52. Seeni A, Takahashi S, Takeshita K et al. Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model. Asian Pac J Cancer Prev 2008; 9: 7-14.
  53. Shang J, Chen L.L, Xiao F.X et al. Resveratrol improves non - alcoholic fatty liver disease by activating AMPactivated protein kinase. Acta Pharmacol Sin 2008; 29: 698-706.
  54. Shi Y, Camici G.G, Lüscher T.F. Cardiovascular determinants of life span. Pflügers Archiv 2010; 459 (2): 315-24.
  55. Singleton R.H, Yan H.Q, Fellows-Mayle W, Dixon C.E. Resveratrol attenuates behavioral impairments and reduces cortical and hippocampal loss in a rat controlled cortical impact model of traumatic brain injury. J Neurotrauma 2010; 27: 1091-9.
  56. Sonmez U, Sonmez A, Erbil G et al. Neuroprotective effects of resveratrol against traumatic brain injury in immature rats. Neurosci Lett 2007; 420: 133-7.
  57. Spanier G, Xu H, Xia N et al. Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). J Physiol Pharmacol 2009; 60: 111-6.
  58. Sutra T, Oiry C, zay-Milhau J et al. Preventive effects of nutritional doses of polyphenolic molecules on cardiac fibrosis associated with metabolic syndrome: Involvement of osteopontin and oxidative stress. J Agric Food Chem 2008; 56: 11683-7.
  59. Szkudelska K, Nogowski L, Szkudelski T. Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes. J Steroid Biochem Mol Biol 2009; 113 (1-2): 17-24.
  60. Taguchi K, Hida M, Matsumoto T et al. Effect of Short - term Polyphenol Treatment on Endothelial Dysfunction and Thromboxane A2 Levels in Streptozotocin-Induced Diabetic Mice. Biol Pharm Bull 2014; 37 (6): 1056-61.
  61. Tangkeangsirisin W, Serrero G. Resveratrol in the chemoprevention and chemotherapy of breast cancer. In: Bagchi D, Preuss H.G, eds. Phytopharmaceuticals in Cancer Chemoprevention. Boca Raton: CRC Press, 2005; p. 449-63.
  62. Tessari P, Coracina A, Cosma A, Tiengo A. Hepatic lipid metabolism and non - alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2009; 19: 291-302.
  63. Thandapilly S.J, Wojciechowski P, Behbahani J et al. Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure. Am J Hypertens 2010; 23: 192-6.
  64. Tilstra J.S, Robinson J, Wang A.R et al. NF-kB inhibition delays DNA damade - induced senescence and aging in mice. J Clin Invest 2012; 122 (7): 2601-12.
  65. Vang O, Ahmad N, Baile C.A et al. What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS One 2011; 6 (6): 198-200.
  66. Vazquez-Agell M, Sacanella E, Tobias E et al. Inflammatory markers of atherosclerosis are decreased after moderate consumption of cava (sparkling wine) in men with low cardiovascular risk. J Nutr 2007; 137: 2279-84.
  67. Vidavalur R, Otani H, Singal P.K, Maulik N. Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp Clin Cardiol 2006; 11 (3): 217-25.
  68. Wallerath T, Li H, Gödtel-Ambrust U et al. blend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase. Nitric Oxide 2005; 12 (2): 97-104.
  69. Wang Z, Zou J, Huang Y et al. Effect of resveratrol on platelet aggregation in vivo and in vitro. Chin Med J (Engl) 2002; 115 (3): 378-80.
  70. Williams L.D, Burdock G.A, Edwards J.A et al. Safety studies conducted on high - purity transresveratrol in experimental animals. Food Chem Toxicol 2009; 49: 2170-221.
  71. Wong R.H, Howe P.R, Buckley J.D et al. Acute resveratrol supplementation improves flow - mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. Nutr Metab Cardiovasc Dis 2010; 3: 23-36; doi: 10.1016/j.numecd.
  72. Xin P, Han H, Gao D et al. Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with up regulation of hepatic low density lipoprotein receptor and scavenger receptor class B type I gene expressions in rats. Food Chem Toxicol 2013; 52: 12-8.
  73. Yang D.L, Zhang H.G, Xu Y.L et al. Resveratrol inhibits right ventricular hypertrophy induced by monocrotaline in rats. Clin Exp Pharmacol Physiol 2010; 37: 150-5.
  74. Yu L, Sun Z.J, Wu S.L, Pan C.E. Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer. World J Gastroenterol 2003; 9: 2341-3.
  75. Zhou H.B, Chen J.J, Wang W.X et al. Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice. World J Gastroenterol 2005; 11: 280-4.
  76. Zhu X, Liu Q, Wang M et al. Activation of Sirt1 by resveratrol inhibits TNF-a induced inflammation in fibroblasts. PLoS One 2011; 6 (11): 3-8.
  77. Wong R.H, Howe P.R, Buckley J.D et al. Acute resveratrol supplementation improves flow - mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. Nutr Metab Cardiovasc Dis 2011; 21 (11): 851-6.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».